Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Harju Elekter Group financial results, 1-3/2026
-
Bitget Publishes Latest Proof of Reserves, Maintaining 130% Backing Across Multi-Asset Platform
-
Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities
-
CaoCao’s Robotaxi Hosts 1,000 International Guests, Showcasing Safe, Stable, and Scalable Operations
-
Crypto News: AlphaPepe Presale Stages Selling Out in Days While Bitcoin Price Prediction Targets $200,000
-
Crypto News: AlphaPepe Ecosystem Expansion Gains Momentum While XRP Price Prediction Targets $8.00
-
Alpha Market Flow’s Research Suggests New Prop Firms Struggle to Gain Trustpilot Reviews
-
Discovery Produces 60,269 Ounces of Gold in First Quarter 2026
-
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
-
Elevra Lithium Quarterly Activities Report
-
Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders
-
Mirastar Federal Credit Union Launches Community Needs Assessment Survey to Deepen Community Listening and Advance Inclusive Financial Solutions
-
The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering
-
Perseus Reports Strong Operational Performance
-
Corporate Update
-
Univest Securities, LLC Ranked 5th in the Q1 2026 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions
-
Century Next Financial Corporation Reports 1st Quarter 2026 Results
-
The 2026 NAB Show Wraps with Proof the Future of Media and Entertainment is Expanding Beyond Broadcasting
-
SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30
-
Clearfield Sets Fiscal Second Quarter 2026 Earnings Call for Wednesday, May 6, 2026
-
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
-
nCino Announces Nick Edwards as Managing Director for APAC
-
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
-
TransUnion Applauds FHFA, HUD for Advancing VantageScore in Mortgage Lending
-
Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026
-
AI GPU Rental Launches New AI-Driven Supercomputing to Simplify Bitcoin Passive Earnings
-
Hammond Power Solutions Announces First Quarter 2026 Financial Results Conference Call and Webcast Notification
-
UNCF Mourns the Passing of Congressman David Scott
-
Home BancShares, Inc. Announces Second Quarter Dividend
-
Canfor releases 2025 Sustainability Report
-
Blue Jay Gold Corp. Appoints Colin Healey to Board Of Directors
-
StorageVault’s Disciplined Operational Execution Delivers Strong Same Store Growth and AFFO Gains in Q1 2026; Increases Dividend
-
Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026
-
Thurgood Marshall College Fund celebrates the lasting impact of U.S. Rep. David Scott
-
News Release for Early Warning Report Regarding Dundee Corporation
-
CEMATRIX to Report First Quarter 2026 Results on April 29, 2026
-
Willis Lease Finance Corporation Announces Timing of First Quarter 2026 Financial Results and Conference Call
-
DELPHX ANNOUNCES NON-BROKERED PRIVATE PLACEMENT
-
XAI Madison Equity Premium Income Fund Will Host its Q1 2026 Quarterly Webinar on May 5th, 2026
-
Oak Valley Bancorp Reports 1st Quarter Results
-
FTI Consulting Expands Data Analytics & AI Healthcare Expertise With Three Senior Hires
-
Prairie Operating Co. Announces Board of Director Resignation
-
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
-
Trident Resources Closes Option Agreement to Acquire Strategic Claims adjoining the Contact Lake Gold Project from North-Sask. Ventures Ltd. within the La Ronge Gold Belt
-
Cielo Announces Historical Recognition Grant of Stock Options
-
AirBoss Announces Details for AGM and Q1 2026 Results Timing
-
GigaCloud Technology Inc Announces Planned Retirement of Head of Brand Center
-
FTI Consulting Expands Data Analytics & AI Healthcare Expertise With Three Senior Hires
-
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous int
-
AMPLIFY Sounds Alarm as PR Firm Linked to Widespread AI Content Theft

